Bellevue Group’s Kymera Therapeutics KYMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-52,400	Closed	-$2.22M	–	178
2022 Q1	$2.22M	Buy	52,400 +3,400	+7%	+$144K	0.03%	132
2021 Q4	$3.11M	Buy	49,000 +13,500	+38%	+$857K	0.03%	137
2021 Q3	$2.09M	Buy	+35,500	New	+$2.09M	0.02%	147